igf-1 lr3 hypoglycemia prevention & (Build Blend) - Peptide Therapies Human conditions of insulin-like growth

This review highlights oxidative stress as a major contributor to brain aging and neurological disease, with the brain particularly vulnerable due to its high metabolic activity

doi: 10.1016/j.bbrc.2016.10.099 174 GrahamDG

PMID: 18073313 Ghigo E, et al

These are peptides that are assumed to stimulate the release of the growth hormones, however are not considered growth hormone releasing peptides themselves

In LR3 IGF-I there is an arginine substitution for the third position glutamic acid and a 13 amino acid N-terminal peptide extension, which is derived from methionyl porcine Growth Hormone

Below, you will find practical guidance on how to enhance results safely and realistically